» Articles » PMID: 25619480

The Role of Gut Microbiota in the Development of Type 1, Type 2 Diabetes Mellitus and Obesity

Overview
Publisher Springer
Specialty Endocrinology
Date 2015 Jan 27
PMID 25619480
Citations 116
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetes is a group of metabolic disorders characterized by persistent hyperglycemia and has become a major public health concern. Autoimmune type 1 diabetes (T1D) and insulin resistant type 2 diabetes (T2D) are the two main types. A combination of genetic and environmental factors contributes to the development of these diseases. Gut microbiota have emerged recently as an essential player in the development of T1D, T2D and obesity. Altered gut microbiota have been strongly linked to disease in both rodent models and humans. Both classic 16S rRNA sequencing and shot-gun metagenomic pyrosequencing analysis have been successfully applied to explore the gut microbiota composition and functionality. This review focuses on the association between gut microbiota and diabetes and discusses the potential mechanisms by which gut microbiota regulate disease development in T1D, T2D and obesity.

Citing Articles

Diabetes and gut microbiome.

Fliegerova K, Mahayri T, Sechovcova H, Mekadim C, Mrazek J, Jarosikova R Front Microbiol. 2025; 15():1451054.

PMID: 39839113 PMC: 11747157. DOI: 10.3389/fmicb.2024.1451054.


The Ocular Microbiome: Micro-Steps Towards Macro-Shift in Targeted Treatment? A Comprehensive Review.

Trojacka E, Izdebska J, Szaflik J, Przybek-Skrzypecka J Microorganisms. 2024; 12(11).

PMID: 39597621 PMC: 11596073. DOI: 10.3390/microorganisms12112232.


Interaction Between Early Meals (Big-Breakfast Diet), Clock Gene mRNA Expression, and Gut Microbiome to Regulate Weight Loss and Glucose Metabolism in Obesity and Type 2 Diabetes.

Jakubowicz D, Matz Y, Landau Z, Rosenblum R, Twito O, Wainstein J Int J Mol Sci. 2024; 25(22).

PMID: 39596418 PMC: 11594859. DOI: 10.3390/ijms252212355.


Dietary nitrate maintains homeostasis of oxidative stress and gut microbiota to promote flap survival in type 2 diabetes mellitus rats.

Niu Q, Li D, Guo W, Feng Z, Han Z, Yang Y BMC Endocr Disord. 2024; 24(1):184.

PMID: 39256735 PMC: 11386097. DOI: 10.1186/s12902-024-01691-5.


Mechanism of Skin Peptides in Alleviating Hyperglycemia in Rats with Type 2 Diabetic Mellitus Based on Microbiome and Metabolome Analyses.

Xu M, Chen B, Qiao K, Liu S, Su Y, Cai S Mar Drugs. 2024; 22(8).

PMID: 39195493 PMC: 11355842. DOI: 10.3390/md22080377.


References
1.
P B . The lean patient with type 2 diabetes: characteristics and therapy challenge. Int J Clin Pract Suppl. 2007; (153):3-9. DOI: 10.1111/j.1742-1241.2007.01359.x. View

2.
Wen L, Ley R, Volchkov P, Stranges P, Avanesyan L, Stonebraker A . Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature. 2008; 455(7216):1109-13. PMC: 2574766. DOI: 10.1038/nature07336. View

3.
Nielsen D, Krych L, Buschard K, Hansen C, Hansen A . Beyond genetics. Influence of dietary factors and gut microbiota on type 1 diabetes. FEBS Lett. 2014; 588(22):4234-43. DOI: 10.1016/j.febslet.2014.04.010. View

4.
Zandman-Goddard G, Peeva E, Shoenfeld Y . Gender and autoimmunity. Autoimmun Rev. 2007; 6(6):366-72. DOI: 10.1016/j.autrev.2006.10.001. View

5.
Wolf K, Daft J, Tanner S, Hartmann R, Khafipour E, Lorenz R . Consumption of acidic water alters the gut microbiome and decreases the risk of diabetes in NOD mice. J Histochem Cytochem. 2014; 62(4):237-50. PMC: 3966285. DOI: 10.1369/0022155413519650. View